Indutrade: Indutrade acquires diagnostic imaging specialist Euromed in Poland

By Modular Finance

Indutrade has signed an agreement to acquire all shares in the Polish company Euromed Medical Solution Sp. z o.o, www.euromed.net.pl, with annual sales of approximately PLN 90 million (SEK 230 million).

Euromed is a technical trading company specialised in diagnostic imaging equipment, primarily ultrasound systems, for healthcare and veterinary applications. The product offering is complemented by fetal monitoring, digital X-ray and mobile CT solutions. The company has a diverse customer base, including public and private hospitals, healthcare providers and insurance companies. Euromed was founded in 2005, has 40 employees and is located in Poznań, Poland.

“Euromed is a high-quality company with strong long-term partnerships, high technical expertise and an offering that fits well within Indutrade. We are happy to welcome Euromed and the team to Indutrade, further strengthening our presence in Poland”, said Bo Annvik, President and CEO of Indutrade.

Closing is conditional upon approval by the Polish competition authority and is expected to be finalised during Q4 2026. Euromed will be included in Indutrade's Business Area Life Science. The acquisition is Indutrade's eleventh in 2026 and is expected to have a marginally positive impact on Indutrade's earnings per share.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.